The quest for novel melanoma therapies : casein kinase 1alpha and the canonical Wnt signaling protein beta-catenin in progression and chemoresistance of malignant melanoma
JavaScript is disabled for your browser. Some features of this site may not work without it.
The quest for novel melanoma therapies : casein kinase 1alpha and the canonical Wnt signaling protein beta-catenin in progression and chemoresistance of malignant melanoma